The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

Jon Batiste revealed that his wife Suleika Jaouad is "doing great" amid her cancer diagnosis during an exclusive interview ...

It's time for researchers to reconsider the current paradigm of cancer as a genetic disease, argues Sui Huang from the ...

A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a breakthrough in understanding the spread of oral squamous cell carcinoma ...

Recently reported positive preliminary data from Phase 1 dose escalation trial of micvotabart pelidotin (“MICVO,” formerly PYX-201), including a confirmed 50% objective response rate by RECIST 1.1 in ...